Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1832)
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
219,758
Price
$19.32
Total Value
$4.25M
Shares Held After
5,055,916
% of Holdings
4.2%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
9,482
Price
$18.21
Total Value
$172.69K
Shares Held After
5,275,674
% of Holdings
0.2%
Avantor, Inc. (AVTR)
MEHRA SANJEEV K — Director
Shares
125,000
Price
$8.01
Total Value
$1.00M
Shares Held After
475,000
% of Holdings
26.3%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
17,591
Price
$76.34
Total Value
$1.34M
Shares Held After
242,662
% of Holdings
6.8%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
16,512
Price
$75.47
Total Value
$1.25M
Shares Held After
260,253
% of Holdings
6.0%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
11,388
Price
$13.02
Total Value
$148.22K
Shares Held After
121,510
% of Holdings
8.6%
HENRY SCHEIN INC (HSIC)
KUEHN KURT P — Director
Shares
2,844
Price
$78.96
Total Value
$224.57K
Shares Held After
15,420
% of Holdings
15.6%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
10,129
Price
$30.19
Total Value
$305.83K
Shares Held After
25,000
% of Holdings
28.8%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
16,086
Price
$76.30
Total Value
$1.23M
Shares Held After
11,714
% of Holdings
57.9%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
21,191
Price
$75.50
Total Value
$1.60M
Shares Held After
27,800
% of Holdings
43.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$548.10
Total Value
$65.77K
Shares Held After
130
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.14
Total Value
$218.86K
Shares Held After
250
% of Holdings
61.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$546.21
Total Value
$262.18K
Shares Held After
650
% of Holdings
42.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
936
Price
$545.05
Total Value
$510.17K
Shares Held After
1,130
% of Holdings
45.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$544.04
Total Value
$448.29K
Shares Held After
2,066
% of Holdings
28.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$542.88
Total Value
$304.01K
Shares Held After
2,890
% of Holdings
16.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.69
Total Value
$216.68K
Shares Held After
3,450
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$540.63
Total Value
$237.88K
Shares Held After
3,850
% of Holdings
10.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,351
Price
$539.84
Total Value
$729.32K
Shares Held After
4,290
% of Holdings
23.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$539.02
Total Value
$303.47K
Shares Held After
5,641
% of Holdings
9.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
647
Price
$537.92
Total Value
$348.04K
Shares Held After
6,204
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$535.99
Total Value
$246.02K
Shares Held After
6,851
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$535.09
Total Value
$706.32K
Shares Held After
7,310
% of Holdings
15.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$533.23
Total Value
$21.33K
Shares Held After
8,630
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$531.54
Total Value
$21.26K
Shares Held After
8,670
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$530.49
Total Value
$63.66K
Shares Held After
8,710
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$530.03
Total Value
$424.02K
Shares Held After
8,830
% of Holdings
8.3%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
11,894
Price
$13.05
Total Value
$155.19K
Shares Held After
198,588
% of Holdings
5.7%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
964
Price
$9.21
Total Value
$8.88K
Shares Held After
22,389
% of Holdings
4.1%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
963
Price
$8.93
Total Value
$8.60K
Shares Held After
23,353
% of Holdings
4.0%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
5,623
Price
$204.13
Total Value
$1.15M
Shares Held After
156,607
% of Holdings
3.5%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
785
Price
$204.13
Total Value
$160.24K
Shares Held After
63,354
% of Holdings
1.2%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
707
Price
$204.13
Total Value
$144.32K
Shares Held After
189,199
% of Holdings
0.4%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,745
Price
$204.13
Total Value
$356.21K
Shares Held After
233,285
% of Holdings
0.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
127
Price
$204.13
Total Value
$25.92K
Shares Held After
262,325
% of Holdings
0.0%
Enhabit, Inc. (EHAB)
Jolley Julie Diane — EVP of Home Health Operations
Shares
2,793
Price
$13.63
Total Value
$38.07K
Shares Held After
137,130
% of Holdings
2.0%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
2,771
Price
$60.11
Total Value
$166.56K
Shares Held After
4,729
% of Holdings
36.9%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
11,269
Price
$60.11
Total Value
$677.36K
Shares Held After
14,731
% of Holdings
43.3%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
2,607
Price
$60.11
Total Value
$156.70K
Shares Held After
4,893
% of Holdings
34.8%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
915
Price
$204.13
Total Value
$186.78K
Shares Held After
150,882
% of Holdings
0.6%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.30
Total Value
$7.65K
Shares Held After
20,406
% of Holdings
2.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.57
Total Value
$7.78K
Shares Held After
20,906
% of Holdings
2.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
300
Price
$15.28
Total Value
$4.58K
Shares Held After
21,406
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
4,968
Price
$59.16
Total Value
$293.91K
Shares Held After
166,818
% of Holdings
2.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
2,427
Price
$58.32
Total Value
$141.53K
Shares Held After
171,786
% of Holdings
1.4%
INTUITIVE SURGICAL INC (ISRG)
Curet Myriam — EVP & Chief Medical Officer
Shares
105
Price
$493.95
Total Value
$51.86K
Shares Held After
0
% of Holdings
100.0%
Aquestive Therapeutics, Inc. (AQST)
Barber Daniel — President and CEO
Shares
180,677
Price
$4.17
Total Value
$753.97K
Shares Held After
1,004,753
% of Holdings
15.2%
Aquestive Therapeutics, Inc. (AQST)
Korczynski Sherry — Chief Commercial Officer
Shares
15,741
Price
$4.17
Total Value
$65.69K
Shares Held After
241,117
% of Holdings
6.1%
Aquestive Therapeutics, Inc. (AQST)
BRAENDER LORI J — Chief Legal Officer
Shares
40,102
Price
$4.17
Total Value
$167.35K
Shares Held After
442,879
% of Holdings
8.3%
Aquestive Therapeutics, Inc. (AQST)
TOTH A ERNEST JR — Chief Financial Officer
Shares
58,254
Price
$4.17
Total Value
$243.09K
Shares Held After
376,112
% of Holdings
13.4%
Showing 651–700 of 1832 transactions (page 14 of 37)